Inventor · disambiguated record
Dearg S Brown
Also filed as: BROWN DEARG · BROWN DEARG S · BROWN DEARG SUTHERLAND
21 granted patents·7 pending applications·696 citations·filing 1989–2012
96Inventor score
Top patents by PatentIndex Score
28 records- 0197US5580870AQuinazoline derivativesZENECA LTD·Filed 1993·Granted Dec 3, 1996·130 cites·12 claims
- 0292US5821246AAniline derivativesZENECA LTD·Filed 1995·Granted Oct 13, 1998·128 cites·13 claims
- 0390US6956037B2Benzamide derivatives for the treatment of diseases mediated by cytokinesASTRAZENECA AB·Filed 2003·Granted Oct 18, 2005·35 cites·13 claims
- 0490US6794380B2Amide derivativesASTRAZENECA AB·Filed 2003·Granted Sep 21, 2004·38 cites·17 claims
- 0590US4943578APiperazine compoundsGLAXO GROUP LTD·Filed 1989·Granted Jul 24, 1990·54 cites·10 claims
- 0689US6548514B1Amide derivativesASTRAZENECA AB·Filed 2000·Granted Apr 15, 2003·33 cites·16 claims
- 0786US7332483B2Amide derivativesASTRAZENECA AB·Filed 2006·Granted Feb 19, 2008·7 cites·12 claims
- 0883US6579872B1Bezamide derivatives for the treatment of diseases mediated by cytokinesASTRAZENECA AB·Filed 1999·Granted Jun 17, 2003·53 cites·10 claims
- 0981US7442704B2Amide derivativesASTRAZENECA AB·Filed 2005·Granted Oct 28, 2008·4 cites·12 claims
- 1081US6821965B1Amidobenzamide derivatives which are useful as cytokine inhibitorsASTERZENECA AB·Filed 1999·Granted Nov 23, 2004·64 cites·10 claims
- 1181US6686467B2Amide derivatives for the treatment of diseases mediated by cytokinesZENECA LTD·Filed 2002·Granted Feb 3, 2004·14 cites·19 claims
- 1280US7060700B2Amide derivatives useful as inhibitors of the production of cytokinesASTRAZENECA AB·Filed 2002·Granted Jun 13, 2006·13 cites·11 claims
- 1379US7008945B1Amide derivativesASTRAZENECA AB·Filed 2000·Granted Mar 7, 2006·10 cites·13 claims
- 1477US6455520B1Benzamide derivatives and their use as cytokine inhibitorsASTRAZENECA AB·Filed 1999·Granted Sep 24, 2002·43 cites·13 claims
- 1569US6432949B1Amide derivatives useful as inhibitors of the production of cytokinesASTRAZENECA AB·Filed 1999·Granted Aug 13, 2002·24 cites·11 claims
- 1667US6465455B1Benzamide derivatives for the treatment of diseases mediated by cytokinesASTRAZENECA AB·Filed 1999·Granted Oct 15, 2002·23 cites·10 claims
- 1766US6498274B1Amide derivatives for the treatment of diseases mediated by cytokinesZENECA LTD·Filed 1998·Granted Dec 24, 2002·21 cites·15 claims
- 1862US7750154B2Amide derivativesASTRAZENECA AB·Filed 2004·Granted Jul 6, 2010·2 cites·19 claims
- 1956US7943776B2Amide derivatives bearing a cyclopropylaminoacarbonyl substituent useful as cytokine inhibitorsASTRAZENECA AB·Filed 2004·Granted May 17, 2011·0 cites·15 claims
- 2056US2008139613A1Chemical CompoundASTRAZENECA AB·Filed 2007·Application pending·0 cites
- 2156US2010093795A1Piperidine Derivative Used for Treating Chemokine Receptor 5 Mediated DiseasesBROWN DEARG SUTHERLAND·Filed 2007·Application pending·0 cites
- 2254US8742124B2Amide derivatives bearing a cyclopropylaminoacarbonyl substituent useful as cytokine inhibitorsASTRAZENECA AB·Filed 2012·Granted Jun 3, 2014·0 cites·9 claims
- 2348US2012004243A1Amide derivatives bearing a cyclopropylaminoacarbonyl substituent useful as cytokine inhibitorsBROWN DEARG SUTHERLAND·Filed 2011·Application pending·0 cites
- 2447US2007112022A1Piperidine derivatives as ccr5 receptor modulatorsBROWN DEARG·Filed 2004·Application pending·0 cites
- 2547US2006205769A1Piperidine or 8-aza-bicyclo[3.2.1]oct-3-yl derivatives useful as modulators of chemokine receptor activityBROWN DEARG·Filed 2004·Application pending·0 cites
- 2643US2008200460A1Chemical CompoundsBROWN DEARG·Filed 2005·Application pending·0 cites
- 2742US7772432B2Amidobenzamide derivatives which are useful as cytokine inhibitorsASTRAZENECA AB·Filed 2004·Granted Aug 10, 2010·0 cites·8 claims
- 2838US2010256120A1Amide derivativesASTRAZENECA AB·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Dearg S Brown files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →